Premium
NovoCure Ltd (N2VC34)
BOV
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | Mr. Frank LeonardCEO & Director | -34,27k | 614,63k | Vente | 17,93 | 149,07k | -18,69% |
| 2026-06-02 | Mr. Kinyip Gabriel LeungIndependent Director | -2,95k | 46,44k | Vente | 15,77 | 89,50k | -3,19% |
| 2026-06-02 | Dr. Allyson J. OceanIndependent Director | -2,95k | 46,44k | Vente | 15,77 | 11,32k | -20,64% |
| 2026-06-02 | Ms. Kristin StaffordIndependent Director | -2,95k | 46,44k | Vente | 15,77 | 11,32k | -20,64% |
| 2026-06-02 | Ms. Jeryl Lynn HillemanIndependent Director | -2,95k | 46,44k | Vente | 15,77 | 13,86k | -17,52% |
| 2026-06-02 | Mr. Timothy John ScannellIndependent Director | -2,95k | 46,44k | Vente | 15,77 | 14,29k | -17,09% |
| 2026-06-02 | Dr. David T. HungIndependent Director | -2,95k | 46,44k | Vente | 15,77 | 20,47k | -12,58% |
| 2026-06-02 | Mr. William Anthony VernonLead Independent Director | -2,95k | 46,44k | Vente | 15,77 | 197,66k | -1,47% |
| 2026-04-28 | Mr. William Anthony VernonLead Independent Director | 21,50k | 244,89k | Derivative Exercise and Retained Stock | 11,39 | 200,60k | 12,00% |
| 2026-03-04 | Dr. Nicolas LeupinInitié | -1,10k | 14,64k | Vente | 13,31 | 30,96k | -3,43% |
| 2026-03-04 | Ms. Ashley CordovaInitié | -17,64k | 234,59k | Sale to Issuer | 13,30 | 422,57k | -4,01% |
| 2026-03-04 | Dr. Uri WeinbergChief Innovation Officer & Chief Medical Officer | -6,41k | 85,31k | Vente | 13,31 | 153,15k | -4,02% |
| 2026-03-04 | Mr. Frank LeonardCEO & Director | -5,61k | 74,60k | Vente | 13,31 | 93,63k | -5,65% |
| 2026-03-04 | Mr. Christoph BrackmannCFO | -6,41k | 85,31k | Vente | 13,31 | 50,87k | -11,19% |
| 2026-03-03 | Mr. William F. DoyleExecutive Chairman | -71,89k | 932,88k | Vente | 12,79 - 13,43 | 128,40k | -35,89% |
| 2026-03-04 | Mr. Mukund ParavasthuCOO | -48,62k | 667,21k | Vente | 13,31 - 13,77 | 72,83k | -40,03% |
| 2026-03-04 | Mr. Michael PuriChief HR Officer | -1,10k | 14,64k | Vente | 13,31 | 88,18k | -1,23% |
| 2026-02-27 | Dr. Uri WeinbergChief Innovation Officer & Chief Medical Officer | -10,73k | 146,86k | Vente | 13,33 - 13,84 | 141,24k | -7,06% |
| 2026-02-27 | Mr. Mukund ParavasthuCOO | -1,96k | 26,75k | Vente | 13,49 - 13,66 | 76,34k | -2,51% |
| 2026-02-27 | Mr. Frank LeonardCEO & Director | -16,97k | 230,58k | Vente | 13,49 - 13,66 | 80,92k | -17,33% |
| 2026-02-27 | Mr. Michael PuriChief HR Officer | -1,44k | 19,69k | Vente | 13,66 | 70,96k | -1,99% |
| 2026-02-27 | Dr. Nicolas LeupinInitié | -1,03k | 14,06k | Vente | 13,66 | 32,06k | -3,11% |
| 2026-02-27 | Ms. Ashley CordovaInitié | -21,18k | 290,44k | Sale to Issuer | 13,67 - 13,75 | 254,94k | -7,67% |
| 2026-01-11 | Mr. Mukund ParavasthuCOO | -2,13k | 30,61k | Sale to Issuer | 14,35 | 78,31k | -2,65% |
| 2025-11-01 | Mr. Mukund ParavasthuCOO | -3,12k | 38,22k | Sale to Issuer | 12,23 - 12,81 | 80,44k | -3,73% |
| 2025-11-04 | Mr. Christoph BrackmannCFO | -7,03k | 86,01k | Sale to Issuer | 12,23 | 38,96k | -15,29% |
| 2025-10-31 | Mr. Michael PuriChief HR Officer | -752,00 | 9,64k | Sale to Issuer | 12,82 | 48,54k | -1,53% |
| 2025-11-01 | Mr. Frank LeonardCEO & Director | -966,00 | 12,37k | Sale to Issuer | 12,81 | 38,97k | -2,42% |
| 2025-09-05 | Ms. Ashley CordovaInitié | 81,55k | 996,86k | Achat | 12,22 | 210,28k | 63,35% |
| 2025-07-29 | Mr. Christoph BrackmannCFO | 20,00k | 231,80k | Achat | 11,50 - 11,63 | 25,90k | 339,10% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
